News

We urge federal policymakers to include innovation leaders—especially from high-tech hubs like San Diego—in these ...
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that in connection ...
Tempest Therapeutics is laying off 21 full-time workers to retain just five, as the cash-strapped Bay Area biotech company ...
PeopleConnect, the parent company of TruthFinder®, also received recognition from the San Diego Union-Tribune's Top ...
Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...
The UC San Diego campus is home to the largest electric vehicle (EV) charging network of any academic institution in the ...
Tariff worries continue hanging over companies as they report their latest financial results and try to provide guidance on ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), a biotechnology company that pioneered the use of human hyaluronidase ...
BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally ...
Topas Therapeutics today announced that it will present clinical Phase 2a data on its lead candidate, TPM502, in celiac disease patients at the upcoming Digestive Disease Week® (DDW) 2025, held from ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...